Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$254K Hold
900
0.1% 64
2025
Q2
$251K Hold
900
0.1% 61
2025
Q1
$280K Sell
900
-139
-13% -$41K 0.12% 59
2024
Q4
$271K Hold
1,039
0.11% 58
2024
Q3
$335K Hold
1,039
0.12% 57
2024
Q2
$325K Hold
1,039
0.13% 57
2024
Q1
$295K Hold
1,039
0.11% 58
2023
Q4
$299K Hold
1,039
0.13% 57
2023
Q3
$279K Hold
1,039
0.14% 55
2023
Q2
$231K Sell
1,039
-100
-9% -$23.2K 0.1% 56
2023
Q1
$275K Hold
1,139
0.13% 54
2022
Q4
$299K Hold
1,139
0.15% 53
2022
Q3
$257K Hold
1,139
0.14% 51
2022
Q2
$277K Sell
1,139
-150
-12% -$36.8K 0.14% 55
2022
Q1
$312K Hold
1,289
0.12% 57
2021
Q4
$290K Sell
1,289
-61
-5% -$12.9K 0.09% 56
2021
Q3
$287K Hold
1,350
0.1% 60
2021
Q2
$329K Hold
1,350
0.12% 58
2021
Q1
$336K Hold
1,350
0.13% 57
2020
Q4
$310K Hold
1,350
0.12% 55
2020
Q3
$343K Hold
1,350
0.16% 55
2020
Q2
$318K Hold
1,350
0.16% 55
2020
Q1
$274K Hold
1,350
0.16% 58
2019
Q4
$325K Hold
1,350
0.14% 54
2019
Q3
$261K Hold
1,350
0.12% 57
2019
Q2
$249K Hold
1,350
0.11% 59
2019
Q1
$256K Hold
1,350
0.13% 60
2018
Q4
$263K Hold
1,350
0.16% 55
2018
Q3
$280K Hold
1,350
0.13% 63
2018
Q2
$249K Hold
1,350
0.13% 63
2018
Q1
$230K Hold
1,350
0.12% 66
2017
Q4
$235K Hold
1,350
0.12% 67
2017
Q3
$252K Hold
1,350
0.13% 68
2017
Q2
$233K Sell
1,350
-150
-10% -$24.4K 0.13% 67
2017
Q1
$246K Hold
1,500
0.15% 64
2016
Q4
$219K Hold
1,500
0.14% 63
2016
Q3
$250K Hold
1,500
0.16% 65
2016
Q2
$228K Hold
1,500
0.15% 64
2016
Q1
$225K Hold
1,500
0.15% 65
2015
Q4
$243K Hold
1,500
0.17% 61
2015
Q3
$207K Hold
1,500
0.16% 65
2015
Q2
$230K Hold
1,500
0.15% 75
2015
Q1
$240K Hold
1,500
0.15% 76
2014
Q4
$211K Sell
1,500
-250
-14% -$39K 0.14% 83
2014
Q3
$246K Buy
+1,750
New +$228K 0.17% 77

Other funds holding AMGN

Stone Run Capital's AMGN Position: Q3 2025 in Review

Stone Run Capital held its Amgen (AMGN) position steady in Q3 2025 at 900 shares worth $254K. The position accounts for 0.1% of the portfolio, ranked #64.

Stone Run Capital first reported a position in AMGN in Q3 2014 and has held it in 45 quarters since. The position peaked at $343K in Q3 2020. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Stone Run Capital held 900 shares of Amgen worth $254K as of Q3 2025.
  • Stone Run Capital left its Amgen share count unchanged in Q3 2025.
  • Amgen made up 0.1% of Stone Run Capital's portfolio in Q3 2025, its #64 holding.
  • Stone Run Capital first reported a position in Amgen in Q3 2014 and has held it in 45 quarters since.
  • Stone Run Capital's Amgen position peaked at $343K in Q3 2020.
  • 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Stone Run Capital's 13F filing for Q3 2025, filed 14 Nov 2025.